Evidence map›Paper›PMID 34726156›Full record

ArticleeLife2021

Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans.

Danika L Hill, Carly E Whyte, Silvia Innocentin, Jia Le Lee, James Dooley, Jiong Wang, Eddie A James, James C Lee, William W Kwok, Martin S Zand and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  3. Antiviral CD4Communications medicine · 2026
    Article
  4. Influenza vaccine-specific CD4NPJ vaccines · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Danika L HillDepartment of Immunology and Pathology, Monash University, Melbourne, Australia.ORCID 0000-0001-6284-7061
Carly E WhyteImmunology Program, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.
Silvia InnocentinImmunology Program, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.
Jia Le LeeImmunology Program, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.
James DooleyImmunology Program, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.
Jiong WangDivision of Nephrology, Department of Medicine and Clinical and Translational Science Institute, University of Rochester Medical Center, Rochester, United States.
Eddie A JamesBenaroya Research Institute at Virginia Mason, Translational Research Program and Tetramer Core Laboratory, Seattle, United States.
James C LeeDepartment of Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
William W KwokBenaroya Research Institute at Virginia Mason, Diabetes Program, Seattle, United States.
Martin S ZandDivision of Nephrology, Department of Medicine and Clinical and Translational Science Institute, University of Rochester Medical Center, Rochester, United States.
Adrian ListonImmunology Program, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.
Edward J CarrImmunology Program, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.ORCID 0000-0001-9343-4593
Michelle A LintermanImmunology Program, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.ORCID 0000-0001-6047-1996
Babraham Institute · GBUniversity of Rochester Medical Center · USBenaroya Research InstituteUniversity of Cambridge · GBUniversity of Washington · US

Funding

Biotechnology and Biological Sciences Research Council BBS/E/B/000C0427Biotechnology and Biological Sciences Research Council BBS/E/B/000C0428Department of HealthWellcome TrustWellcome Trust 105920/Z/14/Z
6 · The paper itself

Abstract

Antibody production following vaccination can provide protective immunity to subsequent infection by pathogens such as influenza viruses. However, circumstances where antibody formation is impaired after vaccination, such as in older people, require us to better understand the cellular and molecular mechanisms that underpin successful vaccination in order to improve vaccine design for at-risk groups. Here, by studying the breadth of anti-haemagglutinin (HA) IgG, serum cytokines, and B and T cell responses by flow cytometry before and after influenza vaccination, we show that formation of circulating T follicular helper (cTfh) cells was associated with high-titre antibody responses. Using Major Histocompatability Complex (MHC) class II tetramers, we demonstrate that HA-specific cTfh cells can derive from pre-existing memory CD4

Indexed as

Antibody FormationVaccinationHemagglutininsHumansInflammationInfluenza VaccinesT Follicular Helper CellsHemagglutininsInfluenza Vaccinesageingantibodiesgerminal centrehumanimmunologyinflammationinfluenzamouset follicular helper cellsvaccines

Identifiers

PMID34726156
PMCPMC8562996
OpenAlexW3209983560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.